Evaluating the potential of deferasirox, a commercial chemical transferrin mimetic, in Ti(IV) anticancer drug design

被引：0
|
作者：
Loza-Rosas, Sergio [1 ]
Vazquez, Alexandra [2 ]
Rivero, Kennett [1 ]
Negron, Lenny [1 ]
Parks, Timothy [3 ]
Tinoco, Arthur [1 ]
机构：
[1] Univ Puerto Rico Rio Piedras, Chem, San Juan, PR 00931 USA
[2] Univ Puerto Rico Rio Piedras, Biol, San Juan, PR 00931 USA
[3] VA Caribbean Hlth Syst, Dept Nursing, San Juan, PR USA
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2016年 / 251卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
1216
引用
收藏
页数：1
相关论文
共 46 条
  • [21] QBD-Powered Design and Optimization of Nanostructured Lipid Carriers Loaded with BCS class IV Anticancer Drug
    Haritha, Pamujula Naga
    Janakiraman, Kunchithapatham
    Madhav, Katla Venu
    Chaitanya, Padavala Sunil Kumar
    INDIAN JOURNAL OF PHARMACEUTICAL EDUCATION AND RESEARCH, 2024, 58 (03) : s828 - s836
  • [22] SH2 AND SH3 DOMAINS - POTENTIAL TARGETS FOR ANTICANCER DRUG DESIGN
    SMITHGALL, TE
    JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS, 1995, 34 (03) : 125 - 132
  • [23] Design, physicochemical confirmation, single crystal structures as well as exploration of antibacterial and anticancer potential of organotin (IV) carboxylates
    Gul, Roshni
    Muhammad, Niaz
    Sirajuddin, Muhammad
    Noor, Awal
    Tumanov, Nikolay
    Wouters, Johan
    Chafik, Abdelbasset
    Solak, Kubra
    Mavi, Ahmet
    Shujah, Shaukat
    Ali, Saqib
    Khan, Gul Shahzada
    Qayyum, Sadaf
    JOURNAL OF MOLECULAR STRUCTURE, 2024, 1300
  • [24] Rational design of potential anticancer "drug-like" molecules based on 4-azoldinone scaffold
    Lesyk, Roman
    Zimenkovsky, Borys
    Kaminskyy, Danylo
    Havryluk, Dmytro
    Atamanyuk, Dmytro
    Kryshchyshyn, Anna
    Subtel'na, Ivanna
    Khyluk, Dmytro
    EUROPEAN BIOPHYSICS JOURNAL WITH BIOPHYSICS LETTERS, 2011, 40 : 109 - 109
  • [25] Design, synthesis and bioactivity investigation of peptide-camptothecin conjugates as anticancer agents with a potential to overcome drug resistance
    Zhang, Chenyu
    Zhong, Honglan
    Li, Xiang
    Xing, Zhenjian
    Liu, Jiaqi
    Yu, Rui
    Deng, Xin
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2023, 645
  • [26] Design and evaluation of the chemical functionalized BxCyNz (x = z=1, y=2) nanotube as an anticancer drug delivery vehicle
    Saadh, Mohamed J.
    Mohammad, Hussein Abdelamir
    Alazragi, Reem S.
    Jawad, Sabrean Farhan
    Shather, A. H.
    Rao, Devendra Pratap
    Abdul-Saheb, Alaa Jasim
    Sharma, Saroj
    Abed, Zainab Talib
    INORGANIC CHEMISTRY COMMUNICATIONS, 2023, 157
  • [27] The potential of a data centred approach & knowledge graph data representation in chemical safety and drug design
    Pavel, Alisa
    Saarimaki, Laura A.
    Mobus, Lena
    Federico, Antonio
    Serra, Angela
    Greco, Dario
    COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL, 2022, 20 : 4837 - 4849
  • [28] Design and synthesis of parthenolide and 5-fluorouracil conjugates as potential anticancer agents against drug resistant hepatocellular carcinoma
    Ding, Yahui
    Li, Shengzu
    Ge, Weizhi
    Liu, Zhongquan
    Zhang, Xuhai
    Wang, Mengmeng
    Chen, Tianyang
    Chen, Yue
    Zhang, Quan
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2019, 183
  • [29] In-silico profiling, design, molecular docking computation, and drug kinetic model evaluation of novel curcumin derivatives as potential anticancer agents
    Jibrin, Anne
    Uzairu, Adamu
    Shallangwa, Gideon Adamu
    Abechi, Stephen Eyije
    Umar, Abdullahi Bello
    JOURNAL OF THE INDIAN CHEMICAL SOCIETY, 2023, 100 (04)
  • [30] In silico design, synthesis and activity of potential drug-like chrysin scaffoldd-erived selective EGFR inhibitors as anticancer agents
    Debnath, Sudhan
    Kanakaraju, Manupati
    Islam, Minarul
    Yeeravalli, Ragini
    Sen, Debanjan
    Das, Amitava
    COMPUTATIONAL BIOLOGY AND CHEMISTRY, 2019, 83
12345